ArticleslgStudy

science

Ology Bioservices

Ology Bioservices is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Ology Bioservices rather than just read about it. In short: Ology Bioservices (previously named Nanotherapeutics, Inc.) is a private, American biopharmaceutical company headquartered in Alachua, Florida. The company was founded with research in nanometer-scale particle technology to develop new drug delivery technologies and increase the efficacy of existing drugs.

Ology Bioservices — main illustration
Ology Bioservices — illustration

Key takeaways

  • Ology Bioservices belongs to science; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Ology Bioservices to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Ology Bioservices from memory before moving on to harder problems.

Reference excerpt

Ology Bioservices (previously named Nanotherapeutics, Inc.) is a private, American biopharmaceutical company headquartered in Alachua, Florida. The company was founded with research in nanometer-scale particle technology to develop new drug delivery technologies and increase the efficacy of existing drugs. In 2016, the company changed their strategic focus and became a biologics contract development and manufacturing company (CDMO) specializing in the manufacturing of vaccines, monoclonal antibodies, recombinant proteins, virus and nucleic acids. The company is a member of the Alliance for Biosecurity and Medical CBRN Defense Consortium.

History Nanotherapeutics was a product of the Sid Martin Biotechnology Incubator of Alachua, Florida. It was established in 2000 as Nanocoat Technologies by James Talton. The company changed its name to Nanotherapeutics in 2002. In 2013, Nanotherapeutics was awarded an Advanced Development & Manufacturing (ADM) contract from the United States Department of Defense. The contract funded the building and outfitting of the Advanced Development & Manufacturing (ADM) 183,000 sq. ft. manufacturing facility. This laid the foundation for the eventual transition from a product development company to a Contract Development & Manufacturing Organization (CDMO). At the end of 2014, Baxter sold its vaccine production technology based on Vero cell culture to Nanotherapeutics. The sale included developed vaccines for H5N1, H1N1 and seasonal influenza, as well as a number of investigational vaccine programs. Nanotherapeutics was co-signatory to a letter dated July 29, 2015 from the Alliance for Biosecurity to U.S. Representatives Susan Brooks and Anna Eshoo in support of the Strengthening Public Health Emergency Response Act of 2015, which "would support preparedness for potential public health emergencies by increasing accountability and streamlining the contracting process for medical countermeasures (MCMs)." In August 2016, Peter H. Khoury, Ph.D., MBA, joined the company as Chief Commercial Officer and was promoted within a year to President and CEO. He implemented a new business model as a dedicated biologics CDMO, which was in line with the growing needs of both the United States Government and commercial enterprises. He also led the rebranding efforts in titling the company Ology Bioservices. As Ology represents an advanced study of a subject or branch of learning (sociology, geology, neurology), the name represents the advanced work the business provides in the area of product development and manufacturing. In October 2017, the company changed its name to Ology Bioservices. Ology was awarded a contract in February 2020 from the United States Government to develop an advanced monoclonal antibody therapy against COVID-19. In April 2021, Ology Bioservices was acquired by National Resilience, Inc. In June 2025, the Alachua site was closed by National Resilience. In November 2025, the ownership of the site was transferred to Strive Pharmacy.

Business model Historically, Nanotherapeutic's product development efforts were based on utilization of nanometer-scale particle technology. This placed at least some of its products in the category of medical devices, such as NanoFuse DBM, approval of which can take advantage of the FDA 510(k) expedited review route. Nanotherapeutics had a history of securing United States government grants and contracts, in particular through the Department of Defense, as a source of revenue. Like many other companies, Nanotherapeutics secured venture capital funding, and entered into product co-development alliances. In October 2017, the company rebranded to Ology Bioservices to align the company name with the new business model. Ology Bioservices has developed a business model that provides biologics CDMO services to the U.S. Government and to commercial companies.

Operations Nanotherapeutics' headquarters were located in Progress Park, which also houses the Sid Martin Biotechnology Incubator in Alachua, Florida, until mid-2016. In late-2014, the company opened an office in Frederick, Maryland to have a presence in close proximity to United States government agencies with which it frequently contracts. At the end of 2014, the company acquired a vaccine manufacturing facility in the Czech Republic from Baxter. In 2015 Nanotherapeutics took over the anti-Botulism program from Xoma Corporation and opened a small facility in Berkeley, California to continue the projects funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. In late 2019, the Berkeley, California site was moved to Alameda, California. The new facility, once complete, will add cell therapy capabilities to Ology Bioservices' offerings. In mid-2016, Nanotherapeutics moved into its new headquarters and manufacturing facility, the Advanced Development & Manufacturing (ADM) facility in Copeland Park, Alachua, FL.

References

Worked examples

Example 1 — a first encounter with Ology Bioservices

Start with the simplest possible case. Write down what Ology Bioservices claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Ology Bioservices before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Ology Bioservices ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Ology Bioservices

In research
Ology Bioservices appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Ology Bioservices in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Ology Bioservices is common in secondary-school and first-year university syllabi. It links to neighbouring topics 2000 establishments in Florida, Companies established in 2000, Contract development and manufacturing organizations, so understanding it makes those chapters shorter.
In everyday life
Look for Ology Bioservices outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Ology Bioservices” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Ology Bioservices in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Ology Bioservices means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Ology Bioservices out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Ology Bioservices in simple terms?

Ology Bioservices (previously named Nanotherapeutics, Inc.) is a private, American biopharmaceutical company headquartered in Alachua, Florida. The company was founded with research in nanometer-scale particle technology to develop new drug delivery technologies and increase the efficacy of existin…

Why does Ology Bioservices matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Ology Bioservices?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Ology Bioservices.

Tags

  • 2000 establishments in Florida
  • Companies established in 2000
  • Contract development and manufacturing organizations
  • Medical and health organizations based in Florida

Keep exploring